by alice | Dec 5, 2025 | Clinicians, Participants, Researchers
In 2018, the findings from the ASPREE trial of low dose aspirin changed clinical guidelines around the world when it reported that there was no overall benefit of taking daily low dose aspirin for 4.7 years in older adults who were initially healthy and free of...
by editor | Jun 21, 2023 | Clinicians, Participants, Researchers
Low-dose aspirin may increase anaemia risk in healthy older adults: study A new study analysing data from the landmark ASPREE trial has found that prolonged daily aspirin use increases the risk of anaemia by 20% in some older adults, mostly aged 70 years or...
by editor | Apr 28, 2022 | Clinicians, Participants, Researchers
International medical expert group latest to cite ASPREE findings in guidelines Major findings from the ASPREE trial have been adopted into influential US Preventive Services Taskforce (USPSTF) new medical aspirin guidelines. The USPSTF recently announced a new...
by Trisha | May 6, 2021 | Clinicians, Participants, Researchers
Analysis shows aspirin’s potential adverse effect on mood in older adults with pre-existing depression Late-life depression is common, yet is often mistaken as a normal part of ageing. For older adults who are diagnosed, treatment is often inadequate....
by editor | Aug 13, 2020 | Clinicians, Participants, Researchers
New analysis identifies potential risk of major GI bleeding in older adults A closer analysis of data from the ASPREE trial provides doctors, for the first time, with information about how much aspirin may increase the risk of gastrointestinal (GI) bleeding in...
Recent Comments